Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 03-10-2022

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to adopt passive investment strategy. The fund will invest in stocks comprising in the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
MSCI India Domestic & World Healthcare 45 Index N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Taurus Ethical Fund - Regular Plan - Growth Option Mar 20, 2009 -1.93 18.28 13.43 2.45 83.83
Sundaram Nifty 100 Equal Weight Fund (Formerly Known as Principal Nifty 100 Equal Weight Fund)-Growth Jul 27, 1999 -2.48 16.85 9.58 0.95 58.30

Fund Holdings as on 31-August-2022

  • Sun Pharmaceutical Industries Ltd.

  • Cipla Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Divi's Laboratories Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • JOHNSON & JOHNSON

  • Laurus Labs Ltd.

  • Max Healthcare Institute Ltd.

  • PFIZER INC

  • Torrent Pharmaceuticals Ltd.

  • ELI LILLY & CO

  • ABBVIE INC

  • Aurobindo Pharma Ltd.

  • Lupin Ltd.

  • MERCK & CO.INC

  • THERMO FISHER SCIENTIFIC INC

  • Fortis Healthcare Ltd.

  • Biocon Ltd.

  • IPCA Laboratories Ltd.

  • DANAHER CORP

  • ABBOTT LABORATORIES

  • NOVARTIS AG

  • Abbott India Ltd.

  • Dr. Lal Path Labs Ltd.

  • AMGEN INC

  • MEDTRONIC PLC

  • Syngene International Ltd.

  • Pfizer Ltd.

  • Ajanta Pharma Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Natco Pharma Ltd.

  • Suven Pharmaceuticals Ltd.

  • Sanofi India Ltd.

  • GILEAD SCIENCES INC

  • GlaxoSmithKline Pharmaceuticals Ltd.

  • INTUITIVE SURGICAL INC

  • BECTON DICKINSON AND CO

  • VERTEX PHARMACEUTICALS INC

  • STRYKER CORP

  • Alembic Pharmaceuticals Ltd.

  • Metropolis Healthcare Ltd.

  • MODERNA INC

  • IQVIA HOLDINGS INC

  • AGILENT TECHNOLOGIES INC

  • Clearing Corporation of India Ltd.

  • ILLUMINA INC

  • Net Receivables/(Payables)

  • Accrued Interest

View More
  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

View More

Fund Manager

  • Cash

  • Equity

View More

About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

Scheme Analysis

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is a Index Funds - Other fund and belongs to Edelweiss Mutual Fund. It was launched on 26-Oct-2020 and currently has an AUM of ₹150.66 crore. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is benchmarked against MSCI India Domestic & World Healthcare 45 Index as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund ended up ₹0.13(1.07%)yesterday to ₹12.0203.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is managed by Bhavesh Jain and Amit Vora.

Fund House Contact

Edelweiss House Off. C.S.T Road, Kalina, Mumbai - 400 098

(022) 40933400
(022) 40933401